PL361014A1 - Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it - Google Patents
Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing itInfo
- Publication number
- PL361014A1 PL361014A1 PL01361014A PL36101401A PL361014A1 PL 361014 A1 PL361014 A1 PL 361014A1 PL 01361014 A PL01361014 A PL 01361014A PL 36101401 A PL36101401 A PL 36101401A PL 361014 A1 PL361014 A1 PL 361014A1
- Authority
- PL
- Poland
- Prior art keywords
- androst
- aza
- ter
- beta
- alpha
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN737DE2000 | 2000-09-07 | ||
| PCT/US2001/019546 WO2002020553A1 (en) | 2000-09-07 | 2001-06-19 | NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL361014A1 true PL361014A1 (en) | 2004-09-20 |
Family
ID=11097081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01361014A PL361014A1 (en) | 2000-09-07 | 2001-06-19 | Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1322663A1 (en) |
| JP (1) | JP2004508380A (en) |
| AU (1) | AU6991101A (en) |
| BR (1) | BR0113732A (en) |
| CA (1) | CA2422159A1 (en) |
| HU (1) | HUP0300937A3 (en) |
| IL (1) | IL154785A0 (en) |
| NO (1) | NO20031045L (en) |
| NZ (1) | NZ525116A (en) |
| PL (1) | PL361014A1 (en) |
| WO (1) | WO2002020553A1 (en) |
| ZA (1) | ZA200302554B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2206065B1 (en) | 2002-10-31 | 2005-08-16 | Ragactives, S.L. | PROCEDURE FOR OBTAINING THE POLYMORPHIC FORM I OF FINASTERIDA. |
| US7550593B2 (en) * | 2003-07-03 | 2009-06-23 | Cipla Limited | Process for the preparation of finasteride Form I |
| CN1294913C (en) * | 2004-12-23 | 2007-01-17 | 鲁南制药集团股份有限公司 | Medication combination of containing finasteride and cyclodextrin or ramification |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ225100A (en) * | 1987-06-29 | 1991-09-25 | Merck & Co Inc | Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates |
| US5237061A (en) * | 1988-10-31 | 1993-08-17 | Merck & Co., Inc. | Methods of synthesizing benign prostatic hypertropic agents and their intermediates |
| US5021575A (en) * | 1989-11-13 | 1991-06-04 | Merck & Co., Inc. | Method for introducing a 1,2 double bond into azasteroids |
| US5091534A (en) * | 1990-08-27 | 1992-02-25 | Merck & Co., Inc. | Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids |
| US5468860A (en) * | 1992-11-19 | 1995-11-21 | Merck & Co., Inc. | New finasteride processes |
-
2001
- 2001-06-19 JP JP2002525173A patent/JP2004508380A/en not_active Withdrawn
- 2001-06-19 AU AU6991101A patent/AU6991101A/en active Pending
- 2001-06-19 BR BR0113732-8A patent/BR0113732A/en not_active Application Discontinuation
- 2001-06-19 NZ NZ525116A patent/NZ525116A/en unknown
- 2001-06-19 IL IL15478501A patent/IL154785A0/en unknown
- 2001-06-19 WO PCT/US2001/019546 patent/WO2002020553A1/en not_active Ceased
- 2001-06-19 HU HU0300937A patent/HUP0300937A3/en unknown
- 2001-06-19 PL PL01361014A patent/PL361014A1/en not_active Application Discontinuation
- 2001-06-19 CA CA002422159A patent/CA2422159A1/en not_active Abandoned
- 2001-06-19 EP EP01948467A patent/EP1322663A1/en not_active Ceased
-
2003
- 2003-03-06 NO NO20031045A patent/NO20031045L/en not_active Application Discontinuation
- 2003-04-01 ZA ZA200302554A patent/ZA200302554B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2422159A1 (en) | 2002-03-14 |
| HUP0300937A3 (en) | 2007-10-29 |
| ZA200302554B (en) | 2004-02-19 |
| NO20031045D0 (en) | 2003-03-06 |
| NZ525116A (en) | 2004-11-26 |
| JP2004508380A (en) | 2004-03-18 |
| HUP0300937A2 (en) | 2007-02-28 |
| IL154785A0 (en) | 2003-10-31 |
| BR0113732A (en) | 2003-07-29 |
| AU6991101A (en) | 2002-03-22 |
| EP1322663A1 (en) | 2003-07-02 |
| NO20031045L (en) | 2003-04-29 |
| WO2002020553A1 (en) | 2002-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2003002757A0 (en) | Process and intermediates for preparing anticancer compounds | |
| AU2002347653A1 (en) | Process for recovering caprolactam | |
| ZA200108623B (en) | Process for preparing imidachloprid. | |
| AU2001242861A1 (en) | Chain extension process | |
| HUP0300114A3 (en) | Process for preparing flavonoid-derivatives | |
| HUP0301649A3 (en) | Process for preparing azacycloalkanoylaminothiazoles | |
| GB2375974B (en) | A process for the preparation of 1, 1, 1, 2-tetrafluoroethane | |
| AUPR503101A0 (en) | Improved leaching process | |
| MXPA03005569A (en) | New process. | |
| AU2001232158A1 (en) | Crystallizing process | |
| AU6991101A (en) | Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it | |
| AU2002240036A1 (en) | Improved printing process | |
| AU2001280244A1 (en) | Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine | |
| AU2001267769A1 (en) | Process | |
| AU2001281892A1 (en) | Process for preparing flavour compounds | |
| AU2001271913A1 (en) | Process guru | |
| GB0021066D0 (en) | Novel process | |
| AU2001272549A1 (en) | Extraction process | |
| GB9914600D0 (en) | Novel,process | |
| AU2002228593A1 (en) | Process for preparing alpha-(3-arylthio)-acetophenones | |
| GB0028697D0 (en) | Novel process | |
| GB0025616D0 (en) | Novel process | |
| GB0021342D0 (en) | Improved Process | |
| AU2001234795A1 (en) | Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one | |
| HU0204443D0 (en) | Process for preparing fluoroformates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |